Justin A. Renz
2015
In 2015, Justin A. Renz earned a total compensation of $1.9M as Former Executive Vice President, Chief Financial Officer & Treasurer at Karyopharm Therapeutics, a 76% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $85,200 |
---|---|
Option Awards | $876,713 |
Salary | $355,000 |
Stock Awards | $537,300 |
Other | $10,980 |
Total | $1,865,193 |
Renz received $876.7K in option awards, accounting for 47% of the total pay in 2015.
Renz also received $85.2K in non-equity incentive plan, $355K in salary, $537.3K in stock awards and $11K in other compensation.
Rankings
In 2015, Justin A. Renz's compensation ranked 5,006th out of 13,638 executives tracked by ExecPay. In other words, Renz earned more than 63.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,006 out of 13,638 | 63rd |
Division Manufacturing | 1,845 out of 5,190 | 65th |
Major group Chemicals And Allied Products | 660 out of 1,854 | 64th |
Industry group Drugs | 525 out of 1,528 | 66th |
Industry Pharmaceutical Preparations | 413 out of 1,182 | 65th |
Source: SEC filing on April 28, 2017.
Renz's colleagues
We found three more compensation records of executives who worked with Justin A. Renz at Karyopharm Therapeutics in 2015.